Placebo News and Research

RSS

Experimental anti-HIV gel is safe for women to use on a daily basis

An experimental anti-HIV gel is safe for women to use on a daily basis, according to researchers at the University of Alabama at Birmingham (UAB) and the University of Pittsburgh School of Medicine.

26 Feb 2008

Abbott receives approval for HUMIRA (Adalimumab) for polyarticular juvenile idiopathic arthritis

Abbott has announced that it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA (adalimumab) as a treatment to reduce signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients four years of age and older.

26 Feb 2008

SSRI anti-depressants found to offer little clinical benefit

According to new research from Britain, new generation anti-depressants could be for many patients a waste of time and money and offer little clinical benefit.

26 Feb 2008

Antioxidants shown not to help children with Down's syndrome develop

Giving children with Down's syndrome antioxidants and nutrients does not help their condition improve at all, according to a study published today on bmj.com.

21 Feb 2008

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

UCB and sanofi-aventis have announced that the U.S. Food and Drug Administration (FDA) approved a New Drug Application (NDA) for XYZAL (levocetirizine dihydrochloride) 0.5 mg/mL oral solution, a prescription antihistamine indicated for the relief of symptoms associated with indoor and outdoor allergies, as well as the treatment of chronic idiopathic urticaria.

20 Feb 2008

L-acetyl carnitine effective ADHD treatment for children with fragile X syndrome

Fragile X syndrome (FXS) is the most common hereditary form of mental retardation.

20 Feb 2008

Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder

Common antidepressant drugs such as Prozac and Zoloft can be effective treatment options for obsessive compulsive disorder (OCD), according to a new review of studies.

20 Feb 2008

Nabilone marijuana-based drug reduces fibromyalgia pain

Patients with fibromyalgia treated with a synthetic form of marijuana, nabilone, showed significant reductions in pain and anxiety in a first-of-its-kind study, published in The Journal of Pain.

17 Feb 2008

Heart-healthy diet may also be good for the prostate

Men who eat a diet low in fat and red meat but high in vegetables and lean protein and who drink alcohol in moderation may not just be doing their hearts a favor.

14 Feb 2008

Probiotics help keep elite athletes fit and well

According to the latest Australian research the immune system of long-distance runners was enhanced by probiotics - dietary supplements containing potentially beneficial bacteria or yeasts.

13 Feb 2008

Avastin cancer drug does well in breast cancer study

A new study on the cancer drug Avastin has found that when the drug is combined with chemotherapy it slowed down the progression of breast cancer.

13 Feb 2008

Oxcarbazepine doesn't prevent migraine

Contrary to some reports, the epilepsy drug oxcarbazepine does not appear to prevent migraine, according to research published in the February 12, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.

12 Feb 2008

Novel drug shows promise in limiting heart attack damage

A novel drug designed to lessen muscle damage from a heart attack has passed initial safety tests at the Duke Clinical Research Institute.

8 Feb 2008

Improving statins

Statin drugs are helping many people lower their cholesterol, but a new study in the February Journal of Lipid Research reveals that statins actually increase the production of another protein that limits their benefit.

8 Feb 2008

Could a simple vitamin A and zinc supplement help protect young children from malaria?

A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.

7 Feb 2008

Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells

Researchers are identifying innovative therapeutics for sickle cell anemia that focus on specific factors in the disease's progression, such as the important role of hydration of the red blood cells.

7 Feb 2008

Enbrel shown to significantly reduced levels of C-reactive protein

Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.

5 Feb 2008

Antiepileptic drug warning from FDA

The U.S. Food and Drug Administration today issued new information to health care professionals to alert them about an increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions.

5 Feb 2008

Novel drug romiplostim significantly improves treatment of dangerous blood disorder

Two clinical trials of the novel drug romiplostim (Nplate) show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura (ITP), a hematologic disorder that can cause uncontrolled bleeding.

5 Feb 2008

Study suggests Risperidone long-acting injection combined with standard treatment helped delay time to relapse in patients with bipolar disorder

Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those who received standard treatment combined with placebo.

4 Feb 2008

Placebo News and Research

Experimental anti-HIV gel is safe for women to use on a daily basis

Abbott receives approval for HUMIRA (Adalimumab) for polyarticular juvenile idiopathic arthritis

SSRI anti-depressants found to offer little clinical benefit

Antioxidants shown not to help children with Down's syndrome develop

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

L-acetyl carnitine effective ADHD treatment for children with fragile X syndrome

Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder

Nabilone marijuana-based drug reduces fibromyalgia pain

Heart-healthy diet may also be good for the prostate

Probiotics help keep elite athletes fit and well

Avastin cancer drug does well in breast cancer study

Oxcarbazepine doesn't prevent migraine

Novel drug shows promise in limiting heart attack damage

Improving statins

Could a simple vitamin A and zinc supplement help protect young children from malaria?

Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells

Enbrel shown to significantly reduced levels of C-reactive protein

Antiepileptic drug warning from FDA

Novel drug romiplostim significantly improves treatment of dangerous blood disorder

Study suggests Risperidone long-acting injection combined with standard treatment helped delay time to relapse in patients with bipolar disorder

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News